These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26685496)

  • 21. Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine.
    Landy S; Altman CA; Xie F
    Adv Ther; 2011 Apr; 28(4):295-303. PubMed ID: 21424735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifedipine in semi-solid formulations for topical use in peripheral vascular disease: preparation, characterization, and permeation assay.
    Santis AK; de Freitas ZM; Ricci-Junior E; de Brito-Gitirana L; Fonseca LB; Santos EP
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1098-106. PubMed ID: 22901029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
    Shakshuki A; Agu RU
    Int J Pharm Compd; 2019; 23(6):496-503. PubMed ID: 31751946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
    Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
    Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of tinnitus with cyclobenzaprine: an open-label study.
    Vanneste S; Figueiredo R; De Ridder D
    Int J Clin Pharmacol Ther; 2012 May; 50(5):338-44. PubMed ID: 22541838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
    da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
    Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
    Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
    Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
    Nada AH; Zaghloul AA; Hedaya MM; Khattab IS
    Acta Pharm; 2014 Sep; 64(3):299-309. PubMed ID: 25296676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Evaluation of Topical Gabapentin Formulations.
    Martin CJ; Alcock N; Hiom S; Birchall JC
    Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28867811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
    Reynolds WJ; Moldofsky H; Saskin P; Lue FA
    J Rheumatol; 1991 Mar; 18(3):452-4. PubMed ID: 1856814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric side effects of cyclobenzaprine.
    Shprecher D; Sloan CT; Sederholm B
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of tricyclic antidepressant-like complications after cyclobenzaprine overdose.
    Bebarta VS; Maddry J; Borys DJ; Morgan DL
    Am J Emerg Med; 2011 Jul; 29(6):645-9. PubMed ID: 20825849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
    Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
    Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin permeation, biodistribution, and expression of topically applied plasmid DNA.
    Kang MJ; Kim CK; Kim MY; Hwang TS; Kang SY; Kim WK; Ko JJ; Oh YK
    J Gene Med; 2004 Nov; 6(11):1238-46. PubMed ID: 15459965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the transmucosal permeability of cyclobenzaprine: A comparative preformulation by standardized and controlled ex vivo and in vitro permeation studies.
    Majid H; Puzik A; Maier T; Eberhard D; Bartel A; Mueller HC; Burckhardt BB
    Int J Pharm; 2021 May; 601():120574. PubMed ID: 33831487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of methadone absorption after topical administration to hospice patients.
    Sylvester RK; Schauer C; Thomas J; Steen P; Weisenberger A
    J Pain Symptom Manage; 2011 May; 41(5):828-35. PubMed ID: 21330095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience.
    Katz WA; Dube J
    Clin Ther; 1988; 10(2):216-28. PubMed ID: 3078905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.